Jan. 15 at 10:51 PM
$CTXR Ran some questions by Gemi today that put
$CTXR and
$CTOR in their right perspective. I have been concerned about trying to figure out how both interact with each other. I am holding only
$CTXR shares and have worried that
$CTOR could drag
$CTXR down. Gemi made a good case that
$CTXR is the main player or driver holding 78% of
$CTOR shares. That the work horse will be Hado-Lido to save the day for the
$CTXR and
$CTOR if needed. With Hado-Lido having superior results in phase 2 trials, as the only prescription option coming to market, it will generate huge profits due to the 10 million people just in the United States needing a better treatment. With cash runs getting low on both
$CTXR and
$CTOR, Gemi sees a high probability that a license agreement will be made soon and tells me to look for the next quartly earning for a annoucement for most likely a licensing deal with upfront cash to help cash run and a royalty package coming from one of the top hemorrhoid company.
